AlTurki Ahmed, Lima Pedro Y, Vidal Alejandro, Toscani Bruno, Diaz Sergio, Garcia Daniel, Montemezzo Mauricio, Al-Dossari Alaa, Bernier Martin L, Hadjis Tomy, Joza Jacqueline, Essebag Vidal
Division of Cardiology, McGill University Health Center, Montreal, Canada.
Division of Cardiology, McGill University Health Center, Montreal, Canada.
J Electrocardiol. 2021 Jan-Feb;64:66-71. doi: 10.1016/j.jelectrocard.2020.12.001. Epub 2020 Dec 9.
Patients with right bundle branch block (RBBB) are less likely to respond to cardiac resynchronization therapy (CRT). We aimed to assess whether patients with RBBB respond to CRT with biventricular fusion pacing.
Consecutive patients with RBBB at a single tertiary care center, who were implanted with a CRT device capable of biventricular fusion pacing using SyncAV programming, were assessed and compared to a historical cohort of CRT patients with RBBB. QRSd was measured and compared during intrinsic conduction, nominal CRT pacing and manual electrocardiogram-based optimized SyncAV programming. Left ventricular ejection fraction (LVEF) was also compared before and 6 months after CRT.
We included 8 consecutive patients with RBBB (group 1) who were able to undergo SyncAV programming and 16 patients with RBBB (group 2) from a historical cohort. In group 1, compared to mean intrinsic conduction QRSd (155 ± 13 ms), mean nominally-paced QRSd was 156 ± 15 ms (ΔQRSd 1.3 ± 11.6; p = 0.77) and SyncAV-optimized paced QRSd was 135 ± 14 ms (ΔQRSd -20.0 ± 20.4; p = 0.03 and ΔQRSd -21.3 ± 16.3; p = 0.008; compared to intrinsic conduction and nominal pacing respectively). In group 2, mean QRSd with nominal pacing was 160 ± 24 ms (ΔQRSd 3.8 ± 33.4; p = 0.66 compared to intrinsic conduction). In group 1, baseline LVEF was 22.1 ± 11.5 and after 6 months of follow-up was 27.8 ± 8.6 (p = 0.047). In group 2, the baseline LVEF was 27.2 ± 10.6 and after 6 months of follow-up was 25.0 ± 10.0 (p = 0.45).
CRT programed to allow biventricular fusion pacing significantly improved electrical synchrony and LVEF in patients with RBBB. Larger studies are required to confirm these findings.
右束支传导阻滞(RBBB)患者对心脏再同步治疗(CRT)的反应可能较差。我们旨在评估RBBB患者对双心室融合起搏的CRT治疗是否有反应。
在一家三级医疗中心,对连续的RBBB患者进行评估,这些患者植入了能够使用SyncAV程控进行双心室融合起搏的CRT设备,并与RBBB的CRT患者历史队列进行比较。在自身心律、标称CRT起搏和基于手动心电图优化的SyncAV程控期间测量并比较QRS时限(QRSd)。还比较了CRT治疗前和治疗6个月后的左心室射血分数(LVEF)。
我们纳入了8例连续的能够进行SyncAV程控的RBBB患者(第1组)和来自历史队列的16例RBBB患者(第2组)。在第1组中,与平均自身心律QRSd(155±13毫秒)相比,平均标称起搏QRSd为156±15毫秒(QRSd变化量1.3±11.6;p=0.77),SyncAV优化起搏QRSd为135±14毫秒(QRSd变化量-20.0±20.4;p=0.03;与自身心律相比)以及QRSd变化量-21.3±16.3;p=0.008;分别与自身心律和标称起搏相比)。在第2组中,标称起搏的平均QRSd为160±24毫秒(与自身心律相比,QRSd变化量3.8±33.4;p=0.66)。在第1组中,基线LVEF为22.1±11.5,随访6个月后为27.8±8.6(p=0.047)。在第2组中,基线LVEF为27.2±10.6,随访6个月后为25.0±10.0(p=0.45)。
程控为允许双心室融合起搏的CRT显著改善了RBBB患者的电同步性和LVEF。需要更大规模的研究来证实这些发现。